Helixor (Mistletoe) Information
contains active ingredient of an aqueous extract
prepared using white-berried mistletoe (Viscum album) from different
the results of extensive research and clinical experience in
practice, various advantages of Iscador treatment have been
in general condition (increase in appetite and weight)
of normal sleep pattern. Improvement in general vitality.
in mental state (depression/anxiety states, courage to face life and
ability to take initiative).
in ‘quality of life’.
addition other major effects are:
of tumour pain
of malignant growth without affecting healthy tissue
effect (increase of the body’s own defence system including a
reduction in susceptibility to infections)
unwanted side-effects from Chemo- and Radiotherapy
the risk of recurrences and metastases
due to bone marrow depression
to reduce the risk of recurrence of tumours while the condition
is in remission
Cervical dysplasia (Papanicolaou stage III)
of the bladder
lectins: mistletoe lectin I, II and III with a total of more than 20
different individual components (isolectins). All lectins can
stimulate cancer cells to “self-destruction“. “Apoptosis“ of
nature is possible and necessary for all healthy cells. This is
because new cells are continually being produced and old cells are
continually dying. Cell death and cell division are thus balanced
Cancer cells have lost this ability and for this reason they
reproduce unregulated and begin to proliferate. If the capability
for apoptosis in cancer cells is reactivated or restored, the tumour
growth can be restricted.
pre- and post-operative treatment with Helixor reduces the risk of
developing recurrences or metastases and promotes the activation of
the immune system, therefore promoting an improved recovery. The use
of Helixor during radiation and/or chemotherapy significantly reduces
side effects of these treatments.
are favourable reactions and are a part of the therapeutic
is it done?
mistletoe (1ml dosage) is given as subcutaneous (shallow) injections
at the abdomen.
treatment is given every other day (3 times a week).
Pharmalogical effects and clinical relevance
+Release of B-endorphin and establish better sleep cycle
+ DNA stabilization : better tolerability of chemo and radiation therapy, less nausea /vomiting & fatigue
+Lower immune suppression and susceptibility to infections
+Increase amount of white blood cells
+Repressed regeneration tumour blood vessel
+May cause apoptosis and necrosis of the tumour
+Broad clinical application as well as pharmacological effects did not show evidence of cytotoxic agents or anti-hormonal agents
+Overall significantly increase life quality and longevity of the patients
well over 100 clinical studies have been carried out with regard to
the use of mistletoe extracts with different types of tumours.
Mistletoe preparations are thus the best and most
researched medicines used in complementary cancer treatment. In the
final analysis, the studies predominantly indicate that mistletoe
therapy is of benefit. The best documented effects are the reduction
in the side effects of conventional treatments such as surgery,
chemotherapy and radiotherapy and an improvement in quality of life.
In some cases, the appearance of metastases can be delayed and
survival time can be prolonged.
study by Bock et al. (2004) demonstrated the safety and efficacy of
a mistletoe preparation in patients with breast cancer. It compared
the medical data of women with breast cancer
only received basic oncological treatment after the surgery with the
data of patients who also received mistletoe extract. When compared
with the control group, the women in the mistletoe group showed
substantially fewer side effects caused by conventional treatments
(radiotherapy, chemotherapy and hormone therapy) and a longer
survival time. The tolerance of the mistletoe therapy was assesed
good to very good.
results from Augustin et al. (2005) show that mistletoe therapy can
also be regarded as safe and effective in cases of malignant
melanoma. Furthermore, it was determined that skin
patients treated with mistletoe extract survived for a clearly
longer period of time. In general, the treatment was well tolerated;
neither serious side effects nor an increase in tumour growth were
In contrast, the incidence rates of metastases were significantly
lower in the mistletoe group as compared to control.
Intestinal and pancreatic cancer
study results are now also demonstrating the efficacy and safety of
mistletoe extracts in patients with intestinal (colorectal) cancer
and pancreatic cancer. The patients in the
group showed considerably fewer side effects caused by conventional
treatments than those in the control group. For example, in the
mistletoe group, only approximately 19% of the
cancer patients and only 14% of the pancreatic cancer patients
developed side effects caused by chemotherapy and/or radiotherapy,
whereas in both control groups almost 50% suffered
these side effects. Likewise, disease- and therapy related symptoms,
such as nausea, vomiting, loss of appetite, depression, fatigue,
sleep disturbances and back pain occurred at a much lower frequency
than in the control group, the physical performance of the patients
was better, they spent much less time in hospital and survived
longer with a better quality of life at the same time. The mistletoe
therapy was also well tolerated. Only very few of the patients
reacted to the mistletoe extract with side effects such as
dizziness, fatigue, depression, slight fever or itching. With almost
a quarter of the patients, so-called local reactions occurred; these
were always slight to medium in terms of intensity and subsequently
subsided completely. No major side effects were observed (Bock et
al. 2007, Matthes et al. 2007).
For more reading:
>> Tel :(905)634-8598 :: :: Email : email@example.com
Serving Communities from Burlington, Hamilton, Oakville, Burloak, Mississauga, Toronto